Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Psychiatry/Psychology | Neurology
Schizophrenia and Schizoaffective Disorders Clinical Trials
A listing of Schizophrenia and Schizoaffective Disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
California
Cerritos : Comprehensive Clinical Development - Cerritos, CA
Schizophrenia
Costa Mesa : CITrials
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25308)
Costa Mesa : CITrials
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)
Costa Mesa : CITrials
A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688 AM2)
Costa Mesa : CITrials
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects Receiving Chronic Stable Atypical Antipsychotic Therapy
Costa Mesa : CITrials
The purpose of this study is to determine whether Iloperidone is effective in the prevention of relapse in patients with schizophrenia
Costa Mesa : CITrials
This is an efficacy study evaluating a experimental treatment for cognitive deficits in adults with schizophrenia.
Culver City : California Clinical Trials Medical Group, Inc. Updated
Do you have schizophrenia or schizoaffective disorder?
Glendale : California Clinical Trials Medical Group, Inc.
An inpatient study comparing different types of the same study medication administered to subjects with schisophrenia, schizoaffective disorder, or schisophreniform disorder.
Glendale : CNS Healthcare
Schizophrenia and Schizoaffective Disorders Study
Imperial : Sun Valley Research Center
Diagnosed with Schizophrenia and Previous Trouble with the Law
Los Angeles : University of Southern California
Genetics of Schizophrenia
Riverside : CITrials
This is an efficacy study evaluating a experimental treatment for cognitive deficits in adults with schizophrenia.
San Diego : CITrials
A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688 AM2)
San Diego : CITrials
This is an efficacy study evaluating a experimental treatment for cognitive deficits in adults with schizophrenia.
Sherman Oaks : Schuster Medical Research Institute
Schizophrenia Inpatient/Outpatient Study
Sherman Oaks : Schuster Medical Research Institute
Schizophrenia Outpatient Clinical Research Study
District of Columbia
Florida
Georgia
Illinois
Chicago : Rush University Medical Center - Treatment Research Center
Schizophrenia Study
Hoffman Estates : Alexian Brothers Hospital Network
A 17-week, Phase 2, Multicenter, Randomized, Double-Blind Study of Treatment with LY2140023 Combined with SOC to placebo Combined with SOC as the Treatment of Patients with DSM-IV-TR Schizophrenia with Prominent Negative Symptoms
Hoffman Estates : Alexian Brothers Hospital Network
A double-blind, placebo and active controlled evaluation of the safety and efficacy of Cariprazine in the acute exacerbation of Schizophrenia
Hoffman Estates : Alexian Brothers Hospital Network
A fifteen month, prospective, randomized, active-controlled, open-label, flexible dose study of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to treatment failure in adults with schizophrenia who have been recently released from jail.
Hoffman Estates : Alexian Brothers Hospital Network
A phase 2, multicenter, double-blind placebo-controlled comparator study of 2 doses of LY2140023 versus placebo in patients with DSM-IV-TR Schizophrenia.
Hoffman Estates : Alexian Brothers Hospital Network
A Phase III, multi-center randomized, 24 week, double-blind, parallel group, placebo controlled study to evaluate efficacy and safety of RO4917838 in stable patients with persistent, predominant negative symptoms of schizophrenia treated with antipsychotics followed by a 28 week, double-blind treatment period
Hoffman Estates : Alexian Brothers Hospital Network
A phase III, multicenter, randomized, 12-week, double-blind, parallel group, placebo controlled study to evaluate the efficacy and safety of R04917838 in patients with sub-optimally controlled symptoms of schizophrenia treated with antipsychotics followed by a 40-week double-blind, parallel-group, placebo controlled treatment period.
Kansas
Wichita : Via Christi Research Updated
Lurasidone for Acute Psychosis
Wichita : Via Christi Research
Study 3-Month and 1-Month Formulations of Paliperidone Palmitate for Schizophrenia
Louisiana
Lake Charles : Lake Charles Clinical Trials
Evaluating the efficacy and safety of RO4917838 in patients with poorly-controlled symptoms of schizophrenia
Lake Charles : Lake Charles Clinical Trials
Evaluating the efficacy and safety of RO4917838 in stable patients with persistent, predominant negative symptoms of schizophrenia
Lake Charles : Lake Charles Clinical Trials
Evaluating the efficacy of lurasidone for the maintenance treatment of adults with schizophrenia
Lake Charles : Lake Charles Clinical Trials
Study of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS) in Smokers
Lake Charles : Lake Charles Clinical Trials
Study of Aripiprazole (intramuscular injection) in the Acute Treatment of Adults with Schizophrenia
Lake Charles : Lake Charles Clinical Trials
Study of brexpiprazole in patients with acute schizophrenia
Lake Charles : Lake Charles Clinical Trials
Study of Low-Dose Lurasidone in Acutely Psychotic Subjects with Schizophrenia
Lake Charles : Lake Charles Clinical Trials
Study of OPC-34712 (brexpiprazole) as Treatment for Adults with Acute Schizophrenia
Lake Charles : Lake Charles Clinical Trials
Study of OPC-34712 as Long-Term Maintenance Treatment for Adults with Schizophrenia
Missouri
New Jersey
Cherry Hill : Center For Emotional Fitness Updated
SCHIZOPHRENIA
Mount Laurel : CRI Lifetree Updated
Do you or a loved one suffer from Schizophrenia or Schizoaffective Disorder?
New York
Utah
Salt lake City : Lifetree Clinical Research Updated
A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate prevention of relapse in patients with schizophrenia receiving either flexible dose iloperidone or placebo in long-term use (up to 26 weeks) followed by up to 52 weeks of open-label extension
Salt lake City : Lifetree Clinical Research Updated
Mosaic: The Management of Schizophrenia in Clinical Practice
Salt Lake CIty : Lifetree Clinical Research
Schizophrenia
Salt Lake City : CRI Lifetree
The primary objective of this study is to evaluate the efficacy of PP3M compared with placebo in delay of the time to first occurrence of relapse of the symptoms of schizophrenia.
Salt lake City : Lifetree Clinical Research Updated
The primary objective of this study is to evaluate the efficacy of PP3M compared with placebo in delay of the time to first occurrence of relapse of the symptoms of schizophrenia.
